Related Experiment Video
Updated: Feb 9, 2026

Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples
Published on: November 13, 2021
Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney
Scott D Bringans1, Jun Ito1, Thomas Stoll1
1Proteomics International, PO Box 3008, Broadway, Nedlands, Perth, Western Australia, WA 6009, Australia.
Abstract:
A protein biomarker discovery workflow was applied to plasma samples from patients at different stages of diabetic kidney disease. The proteomics platform produced a panel of significant plasma biomarkers that were statistically scrutinised against the current gold standard tests on an analysis of 572 patients. Five proteins were significantly associated with diabetic kidney disease defined by albuminuria, renal impairment (eGFR) and chronic kidney disease staging (CKD Stage ≥1, ROC curve of 0.77). The results prove the suitability and efficacy of the process used, and introduce a biomarker panel with the potential to improve diagnosis of diabetic kidney disease.
More Related Videos
Related Concept Videos
Mass Spectrometry: Overview
Tandem Mass Spectrometry
Mass Spectrometry: Isotope Effect
Mass Spectrometry of Amines
Chronic Kidney Disease I: Introduction
Chemical Ionization (CI) Mass Spectrometry

